Patents
Patents for C07K 17 - Carrier-bound or immobilised peptides; Preparation thereof (10,673)
08/2008
08/20/2008EP0772404B1 Production of collagen in the milk of transgenic mammals
08/20/2008CN101247829A Methods for treating fibrotic conditions
08/20/2008CN101247827A Immunogenic production process
08/20/2008CN101245109A Polyglycol single-modificatory recombined human granular leukocyte colony stimulating factor mutant and preparation method thereof
08/20/2008CN100412188C Biologically active native biomatrix composition
08/19/2008US7414024 B-cell differentiation factor (il-6); anticancer agents; antisense agents; monoclonal antibody
08/14/2008US20080193467 Dendritic cell potentiation
08/14/2008US20080193459 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti HSP90 antibodies
08/14/2008US20080193418 Antibodies coupled to detectable marker; lysis; decontaminate surface or organism; detect, prevent and treat infection
08/13/2008EP1709421A4 Methods for diagnosis and pronosis of cancers of epithelial origin
08/13/2008EP1572363A4 High capacity methods for separation, purification, concentration, immobilization and synthesis of compounds and applications based thereupon
08/13/2008EP1133519B1 Functional antagonists of hedgehog activity
08/13/2008CN101240031A Conjugate constructed from normal heptadecyl and RGD peptide, and its preparation method and application
08/13/2008CN101240030A Conjugate constructed from normal undecyl and RGD peptide, and its synthesis and application in medicine
08/13/2008CN101240029A Conjugate constructed from normal heptyl and RGD peptide, and its synthesis method and application
08/13/2008CN101240028A Conjugate constructed from normal pentadecyl and RGD peptide, and its synthesis and application in medicine
08/13/2008CN101240027A Conjugate constructed from normal nonyl and RGD peptide, and its synthesis and application in medicine
08/13/2008CN101240026A Conjugate constructed from normal tridecyl and RGD peptide, and its synthesis and application in medicine
08/12/2008US7411047 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
08/12/2008US7411040 PRO6182 polypeptides
08/12/2008CA2376236C Modification of biological elements
08/07/2008WO2008092228A1 Method of drying biological material
08/07/2008CA2676820A1 Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
08/06/2008EP1951740A2 High affinity siglec ligands
08/06/2008EP1585546B1 Kim-1 antagonists and use to modulate immune system
08/06/2008EP1581645B1 Method for using division arrested cells in screening assays
08/06/2008CN101235088A Preparation of anti-human seminoprotein specificity single chain antibody and application method thereof
08/05/2008US7408042 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
08/05/2008US7408034 PRO20025 polypeptides
08/05/2008US7408033 PRO5995 polypeptides
08/05/2008US7408032 PRO polypeptides; fused to heterologous polypeptide sequences
08/05/2008US7408023 Joining spacer to biopolymers; generate spacer, join to bioplymer, recover biopolymer; conjugation that can be carried out entirely in the solid phase, with minimal disruption to automated synthetic protocols
08/05/2008US7407934 Controlling blood glucose concentration; amylin antagonist such as 25,28,29Pro-h-amylin, pramlintide; reducing gastric motility and delaying gastric emptying
08/05/2008US7407659 Methods of diagnosing pre-eclampsia or eclampsia
08/05/2008US7407651 IFN-β liquid formulations
08/05/2008CA2380902C Process to make a sustained release formulation
07/2008
07/31/2008WO2008091591A1 Polypeptide films and methods
07/31/2008US20080182284 Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes
07/31/2008DE102007005462A1 Producing a hybrimer containing a photochromic or fluorescent protein comprises condensing a metal alkoxide or metal oxide polymer, crosslinking the product and adding the protein
07/31/2008CA2675972A1 Polypeptide films and methods
07/30/2008EP1948696A2 Multilayer films, coatings and microcapsules comprising polypeptides
07/30/2008EP1948695A2 Immunogenic compositions and methods of use
07/30/2008EP1186616B1 Antifucoidan antibody
07/30/2008CN101233230A Static support bed for purification, separation, detection, modification and/or immobilization of target entities and method using thereof
07/30/2008CN101232896A Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure
07/29/2008US7405269 Identification and isolation of novel DNA and recombinant production of novel polypeptides
07/24/2008WO2008030901A3 Biomarker fragments for the detection of human bnp
07/24/2008US20080175853 Virus-like particles for the induction of autoantibodies
07/24/2008US20080175817 Biocompatible material composition adaptable to diverse therapeutic indications
07/24/2008CA2672091A1 Disintegrin variants and pharmaceutical uses thereof
07/23/2008EP1945798A2 Methods for determining the cleavability of substrates
07/23/2008EP1945656A2 Nanocomposites of repeat sequence proteins and phyllosilicate clays and their preparation
07/22/2008US7402663 Obesity, antidiabetic agents
07/22/2008US7402661 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
07/22/2008US7402658 TRAIN-R: a cysteine-rich member of the TNF-receptor family
07/22/2008US7402315 Peptide of given sequence; fused to glutathione-S-transferase; use in immunoassays and vaccines
07/17/2008WO2008083615A1 Complexes comprising angiostatin and its fragments, preparation preparing methods and uses thereof
07/17/2008CA2722078A1 Functional porous substrates for attaching biomolecules
07/17/2008CA2675231A1 A conjugate comprising angiostatin or its fragment, the method for producing the conjugate and use thereof
07/17/2008CA2674378A1 Methods and compositions related to clot binding compounds
07/16/2008EP1944610A1 Engineering affinity ligands for macromolecules
07/16/2008EP1943350A2 Latent procytotoxins and uses thereof
07/16/2008EP1942922A2 Use of complement pathway inhibitors to treat ocular diseases
07/16/2008EP1313440B1 Dental products comprising bone growth enhancing peptide
07/15/2008US7399831 Promotes the growth and differentiation of cells; attached therapeutic agents can be used to promote this process and the gel along with the growing cells can be implanted at a site in vivo where tissue repair is needed; membranes can be used for culturing cells in vitro; delivering drugs in vitro
07/15/2008US7399828 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/15/2008US7399824 PRO19680 antibodies
07/15/2008US7399630 Cell culture vessel having a polymer surface, a cell adhesion resistant material (CAR) bonded to the polymer (e.g., hyaluronic acid), and one or more peptides covalently bound to the CAR material that promote adherence of cells that do not adhere to the CAR layer in the absence of the peptides
07/15/2008US7399601 Nucleotide sequences coding g protein-coupled receptor for use in identifying modulators of taste transductance; artificial sweetners
07/15/2008US7399597 Epitope identification and modification for reduced allergenic activity in proteins targeted for transgenic expression
07/15/2008US7399463 HSA-free formulations of interferon-beta
07/15/2008CA2274149C Peptides and compounds that bind to a receptor
07/10/2008WO2008081938A1 Use of thermostable biotin-binding protein and solid support having the protein bound thereto
07/10/2008US20080167196 Surface for the immobilization of ligands
07/10/2008US20080166350 Nucleotide sequences coding tumor associated antigens for use in diagnosis, prevention and treatment of cell proliferative disorders
07/10/2008CA2673996A1 Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof
07/10/2008CA2673968A1 Use of heat-resistant biotin-binding protein, and solid support having the protein attached thereto
07/09/2008EP1942114A2 Mammalian cytokines; related reagents and methods
07/09/2008EP1165786B1 Polynucleotide synthesis using a processing enzyme
07/09/2008CN101218251A 异二聚体蛋白结合组合物 Heterodimeric protein binding compositions
07/08/2008US7396918 IGF-I fusion polypeptides and therapeutic uses thereof
07/08/2008US7396916 Antibody to a polypeptide overexpressed in tumors
07/08/2008US7396908 OAF065alpha and OAF065beta polypeptides
07/08/2008US7396907 Antibodies that bind PRO6182 polypeptides
07/08/2008US7396906 Pro4399 Polypeptides
07/08/2008US7396903 Process for preparing insulin compounds
07/08/2008US7396682 Genetic engineered protein; joining mammals cells
07/08/2008US7396651 Nucleotide sequences coding G-protein coupled receptor for use in identifying modulator of tase transduction; flavoring and food processing
07/08/2008US7396529 Compositions and methods for regulating receptor clustering
07/08/2008CA2250712C Chimeric isoprenoid synthases and uses thereof
07/03/2008WO2008078167A2 Consensus peptide
07/03/2008WO2008077407A1 Light induced material deposition by molecular immobilization
07/03/2008WO2008077406A2 Coupling of elements
07/03/2008WO2008027162A3 129xe biosensors and their use
07/03/2008CA2673382A1 Consensus biomineralization peptide
07/02/2008EP1938834A1 Treatment of type 1 diabetes before and after expression of predisposition markers
07/02/2008EP1938099A2 Reactive surfaces, substrates and methods for producing and using same
07/02/2008EP1937814A2 Anti-apoptotic protein antibodies
07/02/2008EP1937313A2 Host cell lines for production of antibody constant region with enhanced effector function
07/01/2008US7393931 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins
1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 107